Atlas Trials

Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures

Clinical trial NCT01921205 · COMPLETED

Trial details

NCT number
NCT01921205
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Epilepsy
Start date
2013-08-29
Primary completion
2017-01-24
Enrollment
404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.